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We have shown that in mice heterozygous for deficient
glucose-6-phosphate dehydrogenase (EC. 1.1.1.49) (G6PD)
activity enzyme histochemistry can distinguish two cellular
phenotypes in many tissues including the intestinal mucosa
(Thomas et al., 1988). We have now induced colonic
tumours in mice heterozygous for G6PD deficiency to
determine tumour clonality. Enzyme histochemistry for
G6PD in untreated mice showed uniform high enzyme
activity in the colonic epithelium of normal (C3H and TO)
mice, uniform low enzyme activity in homozygous enzyme
deficient mice (GPDX) (Pretsch et al., 1988) and a mosaic
pattern in the heterozygous C3H x GPDX mice. In these
heterozygous animals patches of negative and patches of
positive crypts were consistently seen, but no mixed activity
crypts were found (Figure 1). This finding shows that large
intestinal crypts in normal biparental animals are derived
embryologically from a single cell, in keeping with a similar
finding in mouse aggregation chimaeras (Ponder et al.,
1985).
Large bowel tumours were induced in 37 twelve-week-old
female mice. Twelve heterozygous (C3H x GPDX), 16
normal (five C3H and eleven TO), and nine GPDX mice
were given 18-28 weekly subcutaneous injections of
15 mgkg- ' of the large bowel specific carcinogen
1,2,dimethylhydrazine (DMH). The animals were then killed,
the large bowel opened, rolled and snap frozen. Paired serial
sections of these 'swiss rolls' were cut at 8-10 levels; one of
each pair was stained with H&E and the other with a
histochemical reaction for G6PD (Thomas et al., 1988).
Consistency of histochemical conditions was ensured by
carrying out the reaction on slides bearing colonic sections
from each of the three mouse genotypes. Tumours were first
Figure 1 Mosaic pattern of histochemical localisation of G6PD
activity in a large bowel from a female mouse heterozygous for
G6PD activity. Frozen section, G6PD histochemical reaction,
scale bar 0.5mm.
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identified in H&E sections before studying the histo-
chemistry. A tumour was defined as an area of dysplasia
including at least two crypts with or without architectural
abnormalities. Single dysplastic crypts were excluded; they
were considered unlikely to be informative in relation to
tumour clonality as normal crypts are monoclonal. The
range of lesions seen closely resembled the changes found in
human familial adenomatous polyposis coli, varying from
monocryptal dysplasia to sessile and polypoid tubular
adenomas. The largest tumour included about 40 crypts in
cross-section, the majority occupied up to 10 crypts. No
carcinomas were seen. The enzyme phenotype of each
tumour identified in the H&E section was determined by
examining the histochemical reaction in the serial section
(Figure 2).
All 32 tumours in the GPDX animals were of uniform low
enzyme type; out of 141 tumours in the normal (C3H and
TO) animals 134 (95%) showed uniform high enzyme
activity while five (3.5%) showed a mixed enzyme pattern
and two (1.5%) showed uniform low enzyme phenotype. In
the heterozygous animals 12 (43%) out of 28 tumours were
of uniform high enzyme phenotype, and 15 (53%) of
uniform low enzyme type, while one (3.6%) was of mixed
enzyme type. The higher tumour incidence in normal mice is
largely due to very high tumour numbers in three animals
killed after a long treatment period.
Tumours were induced in the control animals - normal
and low enzyme type - to investigate the possibility that
enzyme loss or induction was associated with carcinogenesis.
No induction of G6PD activity was seen in the GPDX
animals. Unexpectedly, seven out of 141 tumours induced in
the animals with normal enzyme phenotype showed partial
or complete loss of enzyme activity. Loss of enzyme activity
may occur in tumours in association with loss of differ-
entiation, but the pattern of change of enzyme activity under
these circumstances is often variable and diffuse (Howell et
al., 1985). In contrast, in the 'negative' areas in these seven
tumours the enzyme loss appeared complete and in the five
mixed tumours contrasted sharply with the rest of the
tumour. We also found small numbers of enzyme-negative
non-neoplastic crypts in these animals and have reported our
conclusion that this is due to carcinogen-induced somatic
mutation of the G6PD gene (Griffiths et al., 1988). We
suggest that a mutation preceding or accompanying carcino-
genesis is the likely cause of the tumour enzyme loss
observed in the enzyme-negative and mixed tumours arising
in the carcinogen-treated normal animals.
In heterozygous animals a single mixed tumour was
observed out of 28 otherwise monophenotypic tumours. The
control studies predict that one tumour showing partial or
complete enzyme loss would be expected for every 20
genotypically positive tumours in the heterozygote. The
single polyphenotypic tumour found was therefore in about
the expected frequency for mutational change. In addition
the 'negative' part of the tumour showed the apparent
complete loss of enzyme activity of the mutational change
rather than the low enzyme activity of the GPDX pheno-
type. Adjacent sections on either side of the tumour showed
it to arise within a patch of positive crypts. We therefore
believe that the polyphenotypia in this tumour originated
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Figure 2 H&E (a) and serial section of G6PD histochemistry (b) of two small tumours induced in a heterozygous mouse. The
neoplastic crypts are shown by hatching and the individual tumours are outlined by dots in the line diagram (c). The upper
tumour is of uniform high enzyme activity and the lower tumour of uniform low enzyme activity. The crypts in the adjacent
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from a carcinogen-induced mutation, and that all 28
tumours can be regarded as monophenotypic for analytical
purposes.
In the assessment of clonality of tumours using a
phenotypic marker it is important to consider the
distribution of the marker in the normal tissue. In the colon,
as the individual crypts are derived from single stem cells
and are therefore monophenotypic, it is possible to
determine whether tumours take origin from one or from
more than one crypt, but not to identify whether they arise
from more than one cell within one crypt.
If colonic tumours were derived from more than one crypt
a proportion would still appear monophenotypic because of
the arrangement of the normal crypts in patches of one
phenotype. The most difficult case to separate from single
crypt origin is the derivation of tumours from two adjacent
crypts. To enable us to predict the expected proportion of
such tumours that would be monophenotypic and the
proportion that would be polyphenotypic we have measured
directly the proportion of adjacent crypt pairs in normal
colonic mucosa that are of differing phenotype and the
proportion that are of the same phenotype. To do this we
have recorded the phenotype of each of an average of 600
sequential crypts in 'swiss roll' sections of colon from each
of the five untreated heterozygous animals. Starting with the
first crypt in the series, overlapping pairs (i.e. 1 and 2, 2 and
3, 3 and 4, etc.) were noted to be of either concordant or
discordant phenotype. The crypt pair phenotype index
(CPPI) was defined as the percentage of adjacent crypt pairs
that show a discordant phenotype. For the individual
animals the CPPI was 27.1, 20.0, 23.1, 19.5 and 21.8, mean
22.3. This figure is the expected proportion of polypheno-
typic tumours if all tumours were derived from two adjacent
crypts. These observations could be biased if the patch shape
was consistently related to the direction in which the section
was taken, but no difference was found in a pilot study
comparing longitudinal and transverse sections.
If all the lesions in our study were derived from two
adjacent crypts, the CPPI enables us to predict that an
average of 5.4 out of 28 tumours would be polyphenotypic.
In fact only one was polyphenotypic, and we have given
above the reasons for considering that the polyphenotypia in
this tumour was due to mutation. Ignoring these reasons the
single polyphenotypic tumour is significantly less frequent
than that predicted if all tumours were of two crypt origin
(x2=5.4, P=0.05), while if all 28 are accepted as mono-
phenotypic the result is strong evidence for a monocryptal
origin (X2=7.1, P<0.01).
Our analysis so far has assumed that all tumours show the
same clonal origin. However, in any study of tumour
clonality one must consider the possibility of a hetero-
geneous clonal origin, for example some tumours being
monoclonal and others polyclonal. The findings in our study
are not consistent with a polycryptal origin of all or a
majority of colonic tumours but we cannot exclude the
possibility that a small proportion are of polycryptal origin.
From the CPPI we calculate that consistent monophenotypia
should be demonstrated in several hundred tumours before
we can exclude the possibility that 5% are of polycryptal
origin. That figure increases greatly as the CPPI drops, as it
is likely to in unbalanced mosaics. The crypts counted to
derive the CPPI also allow us to calculate the relative
frequency of the two crypt phenotypes. The overall
percentage of positive crypts in each animal was 56, 67, 51,
45 and 60%, showing that unlike chimaeric animals these
heterozygous enzyme-deficient animals show a balanced
mosaicism.
A comparable study of tumour clonality has been carried
out in chimaeric mice produced by the fusion of two zygotes,
each carrying distinct cytochemically identifiable markers
(Ponder & Wilkinson, 1986). Patch size in these animals is
large, so that the great majority of individual tumours would
appear to be monophenotypic even if polycryptal. All 55
tumours involving patch borders were monophenotypic.
However, tumour involvement of a patch border does not
necessarily imply an origin from crypts immediately adjacent
to or bridging the border, as even small tumours arising
from within patches could expand to involve the border; in
addition almost a quarter of control tumours lost their
phenotypic markers. It is therefore difficult to know how
many tumours were really informative. Despite these
problems the fact that no single polyphenotypic tumour was
seen in this study is in agreement with our conclusions.
Before these results are generalised the problems in using
the two models should be considered. The use of an X-
linked enzyme marker may lead to metabolic differences
between the two cellular phenotypes that make up the
heterozygote. It also means that loss of enzyme activity
could lead to misinterpretation of the cellular genotype. We
feel that these factors are unlikely to be significant in this
study: we have shown that the proportion of the two cell
types in the heterozygote and the proportion of tumours
derived from each cell type is approximately equal, and loss
of enzyme activity occurred in only a small proportion of
control tumours. The use of aggregation chimaeras with two
different markers avoids major metabolic differences, and in
part avoids the problem arising from loss of the phenotypic
marker. However, it introduces problems due to the highly
skewed distribution of the two cellular genotypes in the
chimaera compared with the X-linked mosaic. The
mechanism for this skewed distribution, 7 to 1 in chimaeric
colon in one study (Ponder & Wilkinson, 1986), is not clear:
it may be due to aggregation of cells of like phenotype
during embryogenesis or it may be due to differential growth
rates. If cells of like phenotype in chimaeras are more likely
to grow together than with cells of the alternative phenotype
this is another potential drawback in looking for a possible
polyclonal origin of tumours with this model.
The fact that studies using these two quite different
models reach similar conclusions makes it highly likely that
these carcinogen-induced tumours are indeed of monocryptal
origin.
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